CLINICAL_TRIALS trial_result · 2023-08-21

Clinical Trial Update: A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis [Phase 3]

Phase 3 clinical trial evaluating Rozanolixizumab in adults with generalized myasthenia gravis has completed. The study results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: UCB Biopharma SRL | Conditions: Generalized Myasthenia Gravis | Phase 3 | Status: COMPLETED | Results posted: 2023-08-21